Insider · CIK 0001554742

Dunlap Ryan

Reports to the SEC for 2 companies · VANCOUVER, WA

sec.gov

Transactions

Companies

Filings

CIK

0001554742

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-20	CYDYCytoDyn Inc. · Non-qualified stock option (right to buy)A Award	Director	AAward	+574K sh	—	—	574,385
2024-10-28	CYDYCytoDyn Inc. · Non-qualified stock option (right to buy)A Award	Director	AAward	+800K sh	—	—	800,000
2024-01-03	CYDYCytoDyn Inc. · Non-qualified stock option (right to buy)A Award	Director	AAward	+800K sh	—	—	800,000
2022-09-06	CYDYCytoDyn Inc. · Non-qualified stock option (right to buy)A Award	Director	AAward	+185K sh	—	—	185,333
2016-06-01	SLSSELLAS Life Sciences Group, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+31.3K sh	$1.75	+$54.7K	49,952
2016-06-01	SLSSELLAS Life Sciences Group, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+65.6K sh	$1.85	+$121K	115,577
2016-06-01	SLSSELLAS Life Sciences Group, Inc.M Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	+30K sh	$1.71	+$51.3K	145,577
2016-06-01	SLSSELLAS Life Sciences Group, Inc.S Sale	Former Chief Financial Officer	SSale	−127K sh	$2.18	−$277K	18,702
2016-06-01	SLSSELLAS Life Sciences Group, Inc. · Stock OptionM Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−31.3K sh	—	—	95,625
2016-06-01	SLSSELLAS Life Sciences Group, Inc. · Stock OptionM Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−65.6K sh	—	—	30,000
2016-06-01	SLSSELLAS Life Sciences Group, Inc. · Stock OptionM Exercise/Conversion	Former Chief Financial Officer	MExercise/Conversion	−30K sh	—	—	0
2015-01-16	SLSSELLAS Life Sciences Group, Inc. · Stock Option (right to buy)A Award	Former Chief Financial Officer	AAward	+125K sh	—	—	125,000
2014-12-31	SLSSELLAS Life Sciences Group, Inc.J Other	Former Chief Financial Officer	JOther	+3,846 sh	$1.28	+$4,922.88	11,650
2014-06-30	SLSSELLAS Life Sciences Group, Inc.J Other	Former Chief Financial Officer	JOther	+2,461 sh	$2.60	+$6,398.6	7,804
2013-12-31	SLSSELLAS Life Sciences Group, Inc.J Other	Former Chief Financial Officer	JOther	+2,728 sh	$1.88	+$5,124.548	5,343
2013-11-26	SLSSELLAS Life Sciences Group, Inc. · Stock Option (right to buy)A Award	Former Chief Financial Officer	AAward	+150K sh	—	—	150,000
2013-06-30	SLSSELLAS Life Sciences Group, Inc.J Other	Former Chief Financial Officer	JOther	+1,369 sh	$1.35	+$1,848.15	2,615
2013-01-29	SLSSELLAS Life Sciences Group, Inc. · Stock Option (right to buy)A Award	Former Chief Financial Officer	AAward	+40K sh	—	—	40,000
2012-12-31	SLSSELLAS Life Sciences Group, Inc.J Other	Former Chief Financial Officer	JOther	+1,246 sh	$1.30	+$1,619.8	1,246

Recent filings

Accepted (ET)
Mar 244
Dunlap Ryan0001104659-26-033957
SEC(opens sec.gov)
Oct 304
Dunlap Ryan0001104659-24-112756
SEC(opens sec.gov)
Jan 54
Dunlap Ryan0001104659-24-001952
SEC(opens sec.gov)
Sep 84
Dunlap Ryan0001104659-22-098629
SEC(opens sec.gov)
Jun 74
Galena Biopharma, Inc.0001390478-16-000111
SEC(opens sec.gov)
Jan 204
Galena Biopharma, Inc.0001390478-15-000004
SEC(opens sec.gov)
Jul 24
Galena Biopharma, Inc.0001390478-14-000030
SEC(opens sec.gov)
Jan 224
Galena Biopharma, Inc.0001250853-14-000028
SEC(opens sec.gov)
Nov 274
Galena Biopharma, Inc.0001250853-13-000120
SEC(opens sec.gov)
Jul 34
Galena Biopharma, Inc.0001554742-13-000001
SEC(opens sec.gov)
Jan 314
Dunlap Ryan0001250853-13-000022
SEC(opens sec.gov)

Companies

Address

1111 MAIN STREET, SUITE 660

VANCOUVER, WA, 98660